blocking kit background sniper bs966l (Biocare Medical)
90
Structured Review
Biocare Medical
blocking kit background sniper bs966l
Blocking Kit Background Sniper Bs966l, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+kit+background+sniper+bs966l/background+sniper/pm34519839-65-19-24
Average 90 stars, based on 1 article reviews
Blocking Kit Background Sniper Bs966l, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+kit+background+sniper+bs966l/background+sniper/pm34519839-65-19-24
Average 90 stars, based on 1 article reviews
blocking kit background sniper bs966l - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Activity Assay:Article Title: The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Article Snippet: CD47 is frequently overexpressed on tumor cells and is an attractive therapeutic target.. The mechanism by which antiCD47 immunotherapy eliminates cutaneous lymphoma has not been explored.. We utilized CRISPR/Cas-9 CD47 knock-out, depletion of NK cells, and mice genetically deficient in IFN-γ to elucidate the mechanism of anti-CD47 therapy in a murine model of cutaneous T cell lymphoma (CTCL). Avidin-Biotin Assay:Article Title: The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Article Snippet: CD47 is frequently overexpressed on tumor cells and is an attractive therapeutic target.. The mechanism by which antiCD47 immunotherapy eliminates cutaneous lymphoma has not been explored.. We utilized CRISPR/Cas-9 CD47 knock-out, depletion of NK cells, and mice genetically deficient in IFN-γ to elucidate the mechanism of anti-CD47 therapy in a murine model of cutaneous T cell lymphoma (CTCL). Blocking Assay:Article Title: The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Article Snippet: CD47 is frequently overexpressed on tumor cells and is an attractive therapeutic target.. The mechanism by which antiCD47 immunotherapy eliminates cutaneous lymphoma has not been explored.. We utilized CRISPR/Cas-9 CD47 knock-out, depletion of NK cells, and mice genetically deficient in IFN-γ to elucidate the mechanism of anti-CD47 therapy in a murine model of cutaneous T cell lymphoma (CTCL). |